Executive Summary

Oct 2019
PROSPECTS
Robust flu season and rise in respiratory allergies underpin value growth

The robust 2018/2019 flu season, albeit not as strong as in 2017/2018, led to a record number of flu cases in Italy and an upswing in current value sales for the category. Flu in Italy is characterised by the dominant circulation of the Type A virus, while the number of viral identifications attributable to the Type B virus is low, according to the National Institute of Health’s surveillance network, InfluNet.

Climate and lifestyle trends increase the demand for OTC remedies

The category performance will continue to be impacted heavily by the incidence and extent of flu cases in the country. Meanwhile, sales of antihistamines/allergy remedies (systemic) will continue to be boosted by the outbreak of allergies linked to rising pollution, sedentary lifestyles and more extreme weather conditions due to climate change.

Consumers switch to herbal/traditional products in search of less invasive options

A growing number of Italian consumers are switching to herbal/traditional remedies. Consumers are increasingly focused on maintaining healthy lifestyles and on prevention rather than cure.

COMPETITIVE LANDSCAPE
The leaders benefit from the consumer preference for well-known brands

GSK Consumer Healthcare continues to hold a narrow lead in value sales in a highly fragmented competitive environment in 2019. The company offers a wide portfolio, including decongestants with Rinazina Spray Nasale and Respira Bene, pharyngeal preparations with Gola Action and Golafair and cough remedies with Sinecod Tosse.

New product launches feature format and flavour aspects

Bayer, which withdrew from the category earlier in the review period with the sale of Sobrepin and Sobrefluid and withdrawal of Polaramin, launched Aspi Gola (with flurbiprofen) at the end of 2018. This is an extension of the company’s popular Aspirina brand in analgesics.

Pharyngeal preparations positioned to compete directly with adult mouth care brands

Pharyngeal preparations with flurbiprofen in the spray format, such as Froben Gola, Benactiv Gola and Neoborocillina Gola, among others, are positioned to treat sore throats, but also pain in the oropharyngeal cavity (eg gingivitis, stomatitis, pharyngitis). Therefore, these preparations compete with adult mouth care brands.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Cough, Cold and Allergy (Hay Fever) Remedies in Italy

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Italy with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Italy, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Italy market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Italy?
  • What are the major brands in Italy?
  • What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Cough, Cold and Allergy (Hay Fever) Remedies in Italy - Category analysis

HEADLINES

PROSPECTS

Robust flu season and rise in respiratory allergies underpin value growth
Climate and lifestyle trends increase the demand for OTC remedies
Consumers switch to herbal/traditional products in search of less invasive options

COMPETITIVE LANDSCAPE

The leaders benefit from the consumer preference for well-known brands
New product launches feature format and flavour aspects
Pharyngeal preparations positioned to compete directly with adult mouth care brands

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2014-2019
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2019
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2019
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024

Consumer Health in Italy - Industry Overview

EXECUTIVE SUMMARY

Healthier, more proactive approach stimulates value growth in consumer health
Lifestyle, demographic and self-medication shifts inform demand trends
Joint venture helps GSK Consumer Healthcare gain the leading position in 2019
Liberalisation fosters growing presence of “pharmacy corners”
Positive outlook due to focus on self-medication, segmentation and long-term wellbeing

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources